Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › tenofovir-DF

tenofovir-DF

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials of tenofovir-DF

4 trials tracked of tenofovir-DF: 2 in phase 3 or 4.

4Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 3 2 Phase 2 2
  1. Phase 3 Safety and Efficacy of Switching From Stavudine or Zidovudine to Tenofovir DF in HIV-1 Infected Children Completed
  2. Phase 3 Safety and Efficacy of Tenofovir DF in HIV-1 Infected Adolescents Failing Their Current Antiretroviral Therapy Completed
  3. Phase 2 Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil Completed
  4. Phase 2 A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT) Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Dual-ART and triple-ART both reduce plasma biomarkers of immune activation and neuronal injury
Infectious Disease RCT
Dual-ART and triple-ART both reduce plasma biomarkers of immune activation and neuronal injury Dual-ART Therapy Shows Lower Brain Inflammation for People with HIV
This randomized controlled trial of 238 adults initiating ART found that both dual-ART and triple-ART regimens significantly reduced markers…
A new trial shows that a specific dual-drug treatment may lower markers of brain inflammation and injury in adults living with HIV.
Jul 18, 2026